Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT06008730
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Resectable Lung Non-Small Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biospecimen Collection — PROCEDUREUndergo collection of blood samples
- Proton Beam Radiation Therapy — RADIATIONUndergo proton beam radiation therapy
- Radiology, Treatment Planning — OTHERUndergo radiation treatment planning
Study Details
This clinical trial tests proton beam radiation therapy in patients with non-small cell lung cancer who have undergone surgical resection and have lymph nodes involving the middle of the chest. Proton therapy is a type of radiation treatment that kills cancer cells while avoiding surrounding healthy tissue. Proton beam therapy is sometimes used after cancer surgery to reduce the risk of cancer recurrence (coming back). Giving proton beam radiation therapy may work better than conventional radiation treatment after surgery in patients with non-small cell lung cancer.
Key Dates
- Start date
- Dec 13, 2024
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (proton beam radiation therapy)Patients undergo radiation treatment planning and then undergo proton beam radiation therapy on study. Patients also undergo collection of blood samples.
Primary Outcome Measure
Incidence of adverse events (AEs) [ Time Frame: Up to 90 days from enrollment ]
Central Contacts
- Bill Stokes, MD404-778-3473
- Aparna H. Kesarwala, MD, PhD404-778-3473
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | Atlanta | Georgia | 30322 | Tegan VandenBosch William Stokes, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
By research site
Related Studies
- Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerPHASE3 · Recruiting · Alliance for Clinical Trials in Oncology · Birmingham, Alabama
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruiting · Mayo Clinic · Phoenix, Arizona
- Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS TrialRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio